speb/financial-data huggingface dataset:
TCRT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1160000.00
TCRT income_statement (annual, 2022-12-31) — Pretax Income: -37730000.00
TCRT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 21000.00
TCRT balance_sheet (annual, 2022-12-31) — Properties: 0.00
TCRT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -216000.00
TCRT balance_sheet (annual, 2022-12-31) — Receivables: 4000.00
TCRT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2759000.00
TCRT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -8333000.00
TCRT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -45000.00
TCRT income_statement (annual, 2022-12-31) — Research And Development: 25018000.00
TCRT balance_sheet (annual, 2022-12-31) — Restricted Cash: 13938000.00
TCRT income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
TCRT balance_sheet (annual, 2022-12-31) — Retained Earnings: -880627000.00
TCRT cash_flow (annual, 2022-12-31) — Sale Of PPE: 23000.00
TCRT income_statement (annual, 2022-12-31) — Selling General And Administration: 13142000.00
TCRT balance_sheet (annual, 2022-12-31) — Share Issued: 1602738.00
TCRT income_statement (annual, 2022-12-31) — Special Income Charges: 133000.00
TCRT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3528000.00
TCRT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 38555000.00
TCRT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 38555000.00
TCRT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (annual, 2022-12-31) — Total Assets: 64937000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Capitalization: 38555000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Debt: 19511000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 38555000.00
TCRT income_statement (annual, 2022-12-31) — Total Expenses: 38160000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 26382000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 11138000.00
TCRT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2216000.00
TCRT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -35105000.00
TCRT income_statement (annual, 2022-12-31) — Total Unusual Items: 133000.00
TCRT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 133000.00
TCRT balance_sheet (annual, 2022-12-31) — Working Capital: 29633000.00
TCRT income_statement (annual, 2023-12-31) — +Operating Expense: 28498000.00
TCRT income_statement (annual, 2023-12-31) — +Total Revenue: 5000.00
TCRT balance_sheet (annual, 2023-12-31) — Accounts Payable: 616000.00
TCRT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1000.00
TCRT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -13000.00
TCRT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 922072000.00
TCRT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4803000.00
TCRT income_statement (annual, 2023-12-31) — Basic Average Shares: 1599532.00
TCRT income_statement (annual, 2023-12-31) — Basic EPS: -21.97
TCRT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 52996000.00
TCRT balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 0.00
TCRT cash_flow (annual, 2023-12-31) — Capital Expenditure: -197000.00
TCRT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
TCRT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 6062000.00
TCRT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 6062000.00
TCRT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -18138000.00
TCRT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 1346000.00
TCRT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -30142000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Account Payable: -773000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -3989000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 500000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -138000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Payable: -773000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -4762000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1357000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Receivables: 3000.00
TCRT cash_flow (annual, 2023-12-31) — Change In Working Capital: -6254000.00
TCRT cash_flow (annual, 2023-12-31) — Changes In Cash: -46934000.00
TCRT balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
TCRT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6307000.00
TCRT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 92000.00
TCRT cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1297000.00
TCRT balance_sheet (annual, 2023-12-31) — Current Assets: 8261000.00
TCRT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Current Liabilities: 1956000.00
TCRT cash_flow (annual, 2023-12-31) — Depreciation: 2315000.00
TCRT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2315000.00
TCRT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2315000.00
TCRT income_statement (annual, 2023-12-31) — Diluted Average Shares: 1599532.00
TCRT income_statement (annual, 2023-12-31) — Diluted EPS: -21.97
TCRT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -35140000.00
TCRT income_statement (annual, 2023-12-31) — EBIT: -33219000.00
TCRT income_statement (annual, 2023-12-31) — EBITDA: -30904000.00
TCRT cash_flow (annual, 2023-12-31) — End Cash Position: 6062000.00
TCRT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -18138000.00
TCRT cash_flow (annual, 2023-12-31) — Free Cash Flow: -30339000.00
TCRT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 7000.00
TCRT income_statement (annual, 2023-12-31) — General And Administrative Expense: 12219000.00
TCRT balance_sheet (annual, 2023-12-31) — Gross PPE: 15000.00
TCRT income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 4803000.00
TCRT income_statement (annual, 2023-12-31) — Interest Expense: 1921000.00
TCRT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1921000.00
TCRT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2063000.00
TCRT balance_sheet (annual, 2023-12-31) — Invested Capital: 6307000.00
TCRT cash_flow (annual, 2023-12-31) — Investing Cash Flow: 1346000.00
TCRT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 92000.00
TCRT balance_sheet (annual, 2023-12-31) — Leases: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
TCRT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -18105000.00
TCRT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 15000.00
TCRT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 92000.00
TCRT income_statement (annual, 2023-12-31) — Net Income: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -35140000.00
TCRT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -35140000.00
TCRT income_statement (annual, 2023-12-31) — Net Interest Income: -1921000.00
TCRT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -18105000.00
TCRT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -18105000.00
TCRT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1921000.00
TCRT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -125000.00
TCRT balance_sheet (annual, 2023-12-31) — Net PPE: 2000.00
TCRT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 1346000.00
TCRT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 6307000.00
TCRT balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
TCRT income_statement (annual, 2023-12-31) — Normalized EBITDA: -25130000.00
TCRT income_statement (annual, 2023-12-31) — Normalized Income: -29366000.00
TCRT cash_flow (annual, 2023-12-31) — Operating Cash Flow: -30142000.00
TCRT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 7000.00
TCRT income_statement (annual, 2023-12-31) — Operating Income: -28493000.00
TCRT income_statement (annual, 2023-12-31) — Operating Revenue: 5000.00
TCRT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1601252.00
TCRT balance_sheet (annual, 2023-12-31) — Other Current Assets: 2198000.00
TCRT income_statement (annual, 2023-12-31) — Other Gand A: 12219000.00
TCRT income_statement (annual, 2023-12-31) — Other Income Expense: -4726000.00
TCRT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1327000.00
TCRT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1048000.00
TCRT income_statement (annual, 2023-12-31) — Other Special Charges: -298000.00
TCRT balance_sheet (annual, 2023-12-31) — Payables: 616000.00
TCRT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1913000.00
TCRT balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 43000.00
TCRT income_statement (annual, 2023-12-31) — Pretax Income: -35140000.00
TCRT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Properties: 0.00
TCRT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -197000.00
TCRT balance_sheet (annual, 2023-12-31) — Receivables: 1000.00
TCRT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2315000.00
TCRT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -18105000.00
TCRT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
TCRT income_statement (annual, 2023-12-31) — Research And Development: 16279000.00
TCRT balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
TCRT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1269000.00
TCRT balance_sheet (annual, 2023-12-31) — Retained Earnings: -915767000.00
TCRT cash_flow (annual, 2023-12-31) — Sale Of PPE: 1543000.00
TCRT income_statement (annual, 2023-12-31) — Selling General And Administration: 12219000.00
TCRT balance_sheet (annual, 2023-12-31) — Share Issued: 1601252.00
TCRT income_statement (annual, 2023-12-31) — Special Income Charges: -5774000.00
TCRT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2800000.00
TCRT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6307000.00
TCRT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6307000.00
TCRT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Total Assets: 8263000.00
TCRT balance_sheet (annual, 2023-12-31) — Total Capitalization: 6307000.00
TCRT balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
TCRT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6307000.00
TCRT income_statement (annual, 2023-12-31) — Total Expenses: 28498000.00
TCRT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1956000.00
TCRT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2000.00
TCRT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
TCRT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -34267000.00
TCRT income_statement (annual, 2023-12-31) — Total Unusual Items: -5774000.00
TCRT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5774000.00
TCRT balance_sheet (annual, 2023-12-31) — Working Capital: 6305000.00
TCRT income_statement (quarterly, 2024-09-30) — Basic Average Shares: 1601252.00
TCRT income_statement (quarterly, 2024-09-30) — Basic EPS: -0.70
TCRT cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 1601252.00
TCRT income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.70
TCRT cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
TCRT income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 1007000.00
TCRT income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Interest Expense: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Net Interest Income: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 0.00
TCRT balance_sheet (quarterly, 2024-09-30) — Net PPE: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Other Gand A: 1007000.00
TCRT cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
TCRT cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
TCRT income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
TCRT income_statement (annual, 2024-12-31) — +Operating Expense: 4822000.00
TCRT income_statement (annual, 2024-12-31) — +Total Revenue: 10000.00
TCRT balance_sheet (annual, 2024-12-31) — Accounts Payable: 516000.00
TCRT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 5000.00
TCRT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -15000.00
TCRT balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -15000.00
TCRT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 922507000.00
TCRT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
TCRT income_statement (annual, 2024-12-31) — Basic Average Shares: 1601252.00
TCRT income_statement (annual, 2024-12-31) — Basic EPS: -2.92
TCRT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 6062000.00
TCRT balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
TCRT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1091000.00
TCRT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1091000.00
TCRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 0.00
TCRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
TCRT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4971000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Account Payable: -100000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1164000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: 0.00
TCRT cash_flow (annual, 2024-12-31) — Change In Payable: -100000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1264000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 539000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Receivables: -4000.00
TCRT cash_flow (annual, 2024-12-31) — Change In Working Capital: -729000.00
TCRT cash_flow (annual, 2024-12-31) — Changes In Cash: -4971000.00
TCRT balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
TCRT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2063000.00
TCRT cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 176000.00
TCRT balance_sheet (annual, 2024-12-31) — Current Assets: 2755000.00
TCRT balance_sheet (annual, 2024-12-31) — Current Liabilities: 692000.00
TCRT cash_flow (annual, 2024-12-31) — Depreciation: 2000.00
TCRT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2000.00
TCRT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2000.00
TCRT income_statement (annual, 2024-12-31) — Diluted Average Shares: 1601252.00
TCRT income_statement (annual, 2024-12-31) — Diluted EPS: -2.92
TCRT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4679000.00
TCRT income_statement (annual, 2024-12-31) — EBIT: -4812000.00
TCRT income_statement (annual, 2024-12-31) — EBITDA: -4810000.00
TCRT cash_flow (annual, 2024-12-31) — End Cash Position: 1091000.00
TCRT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 0.00
TCRT cash_flow (annual, 2024-12-31) — Free Cash Flow: -4971000.00
TCRT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
TCRT income_statement (annual, 2024-12-31) — General And Administrative Expense: 4460000.00
TCRT income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 845000.00
TCRT balance_sheet (annual, 2024-12-31) — Gross PPE: 15000.00
TCRT balance_sheet (quarterly, 2024-12-31) — Gross PPE: 15000.00
TCRT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
TCRT income_statement (annual, 2024-12-31) — Interest Expense: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
TCRT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
TCRT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Invested Capital: 2063000.00
TCRT cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
TCRT cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
TCRT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 15000.00
TCRT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 15000.00
TCRT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
TCRT income_statement (annual, 2024-12-31) — Net Income: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4679000.00
TCRT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -4679000.00
TCRT income_statement (annual, 2024-12-31) — Net Interest Income: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Net Interest Income: 0.00
TCRT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
TCRT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
TCRT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Net PPE: 0.00
TCRT balance_sheet (quarterly, 2024-12-31) — Net PPE: 0.00
TCRT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
TCRT cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2063000.00
TCRT income_statement (annual, 2024-12-31) — Normalized EBITDA: -4810000.00
TCRT income_statement (annual, 2024-12-31) — Normalized Income: -4679000.00
TCRT cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4971000.00
TCRT income_statement (annual, 2024-12-31) — Operating Income: -4812000.00
TCRT income_statement (annual, 2024-12-31) — Operating Revenue: 10000.00
TCRT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1601252.00
TCRT balance_sheet (annual, 2024-12-31) — Other Current Assets: 1659000.00
TCRT balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1659000.00
TCRT income_statement (annual, 2024-12-31) — Other Gand A: 4460000.00
TCRT income_statement (quarterly, 2024-12-31) — Other Gand A: 845000.00
TCRT income_statement (annual, 2024-12-31) — Other Income Expense: 133000.00
TCRT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 133000.00
TCRT balance_sheet (annual, 2024-12-31) — Payables: 516000.00
TCRT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 692000.00
TCRT balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
TCRT balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
TCRT balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
TCRT cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
TCRT income_statement (annual, 2024-12-31) — Pretax Income: -4679000.00
TCRT cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Receivables: 5000.00
TCRT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2000.00
TCRT cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
TCRT income_statement (annual, 2024-12-31) — Research And Development: 362000.00
TCRT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Retained Earnings: -920446000.00
TCRT cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
TCRT cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
TCRT income_statement (annual, 2024-12-31) — Selling General And Administration: 4460000.00
TCRT balance_sheet (annual, 2024-12-31) — Share Issued: 1601252.00
TCRT income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
TCRT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 435000.00
TCRT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2063000.00
TCRT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2063000.00
TCRT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Total Assets: 2755000.00
TCRT balance_sheet (annual, 2024-12-31) — Total Capitalization: 2063000.00
TCRT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2063000.00
TCRT income_statement (annual, 2024-12-31) — Total Expenses: 4822000.00
TCRT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 692000.00
TCRT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
TCRT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4812000.00
TCRT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
TCRT balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
TCRT income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
TCRT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TCRT income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
TCRT balance_sheet (annual, 2024-12-31) — Working Capital: 2063000.00
TCRT income_statement (quarterly, 2025-03-31) — +Operating Expense: 1094000.00
TCRT income_statement (quarterly, 2025-03-31) — +Total Revenue: 2000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 831000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 922575000.00
TCRT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1601252.00
TCRT income_statement (quarterly, 2025-03-31) — Basic EPS: -0.67
TCRT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1091000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 319000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 319000.00
TCRT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -772000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 315000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 55000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Payable: 315000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 370000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -140000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3000.00
TCRT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 233000.00
TCRT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -772000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1058000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 231000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Current Assets: 1067000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1062000.00
TCRT cash_flow (quarterly, 2025-03-31) — Depreciation: 0.00
TCRT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 0.00
TCRT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 0.00
TCRT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1601252.00
TCRT income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.67
TCRT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — EBIT: -1092000.00
TCRT income_statement (quarterly, 2025-03-31) — EBITDA: -1092000.00
TCRT cash_flow (quarterly, 2025-03-31) — End Cash Position: 319000.00
TCRT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -772000.00
TCRT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
TCRT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1058000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1073000.00
TCRT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1073000.00
TCRT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1073000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1058000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1053000.00
TCRT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1092000.00
TCRT income_statement (quarterly, 2025-03-31) — Normalized Income: -1073000.00
TCRT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -772000.00
TCRT income_statement (quarterly, 2025-03-31) — Operating Income: -1092000.00
TCRT income_statement (quarterly, 2025-03-31) — Operating Revenue: 2000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1601252.00
TCRT income_statement (quarterly, 2025-03-31) — Other Income Expense: 19000.00
TCRT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 19000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Payables: 831000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1062000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 746000.00
TCRT income_statement (quarterly, 2025-03-31) — Pretax Income: -1073000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Receivables: 2000.00
TCRT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 0.00
TCRT income_statement (quarterly, 2025-03-31) — Research And Development: 347000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -921519000.00
TCRT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 747000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Share Issued: 1601252.00
TCRT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 68000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1058000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1058000.00
TCRT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Assets: 2120000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1058000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1058000.00
TCRT income_statement (quarterly, 2025-03-31) — Total Expenses: 1094000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1062000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1053000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
TCRT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1092000.00
TCRT balance_sheet (quarterly, 2025-03-31) — Working Capital: 5000.00
TCRT income_statement (quarterly, 2025-06-30) — +Operating Expense: 1039000.00
TCRT income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
TCRT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 809000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 926229000.00
TCRT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1676345.00
TCRT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.63
TCRT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 319000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2879000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2879000.00
TCRT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -701000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -22000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 35000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Payable: -22000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 13000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 122000.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Receivables: 0.00
TCRT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 135000.00
TCRT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2560000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3661000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 265000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Current Assets: 3738000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1074000.00
TCRT cash_flow (quarterly, 2025-06-30) — Depreciation: 0.00
TCRT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 0.00
TCRT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 0.00
TCRT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1676345.00
TCRT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.63
TCRT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — EBIT: -1039000.00
TCRT income_statement (quarterly, 2025-06-30) — EBITDA: -1039000.00
TCRT cash_flow (quarterly, 2025-06-30) — End Cash Position: 2879000.00
TCRT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -701000.00
TCRT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -31000.00
TCRT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 854000.00
TCRT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
TCRT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3661000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1051000.00
TCRT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1051000.00
TCRT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1051000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3661000.00
TCRT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1008000.00
TCRT income_statement (quarterly, 2025-06-30) — Normalized Income: -1020000.00
TCRT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -701000.00
TCRT income_statement (quarterly, 2025-06-30) — Operating Income: -1039000.00
TCRT income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
TCRT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 2074746.00
TCRT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 857000.00
TCRT income_statement (quarterly, 2025-06-30) — Other Gand A: 854000.00
TCRT income_statement (quarterly, 2025-06-30) — Other Income Expense: -12000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 997000.00
TCRT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 19000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Payables: 809000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1074000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
TCRT income_statement (quarterly, 2025-06-30) — Pretax Income: -1051000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Receivables: 2000.00
TCRT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 0.00
TCRT income_statement (quarterly, 2025-06-30) — Research And Development: 185000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -922570000.00
TCRT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 854000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Share Issued: 1978246.00
TCRT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 184000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3661000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3661000.00
TCRT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Assets: 4735000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3661000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3661000.00
TCRT income_statement (quarterly, 2025-06-30) — Total Expenses: 1039000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1074000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 997000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
TCRT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1039000.00
TCRT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -31000.00
TCRT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -31000.00
TCRT balance_sheet (quarterly, 2025-06-30) — Working Capital: 2664000.00
TCRT income_statement (quarterly, 2025-09-30) — +Operating Expense: 1187000.00
TCRT income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 843000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 926530000.00
TCRT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2183039.00
TCRT income_statement (quarterly, 2025-09-30) — Basic EPS: -0.55
TCRT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2879000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1938000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1938000.00
TCRT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -844000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 34000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -188000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Payable: 34000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -154000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 166000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2000.00
TCRT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 14000.00
TCRT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -941000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2803000.00
TCRT cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 78000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Current Assets: 2685000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 921000.00
TCRT cash_flow (quarterly, 2025-09-30) — Depreciation: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 2183039.00
TCRT income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.55
TCRT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — EBIT: -1187000.00
TCRT income_statement (quarterly, 2025-09-30) — EBITDA: -1187000.00
TCRT cash_flow (quarterly, 2025-09-30) — End Cash Position: 1938000.00
TCRT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -941000.00
TCRT cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
TCRT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 718000.00
TCRT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2803000.00
TCRT cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1159000.00
TCRT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1159000.00
TCRT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1159000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Net PPE: 97000.00
TCRT cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2803000.00
TCRT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1187000.00
TCRT income_statement (quarterly, 2025-09-30) — Normalized Income: -1159000.00
TCRT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -844000.00
TCRT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Operating Income: -1187000.00
TCRT income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2205846.00
TCRT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 747000.00
TCRT income_statement (quarterly, 2025-09-30) — Other Gand A: 718000.00
TCRT income_statement (quarterly, 2025-09-30) — Other Income Expense: 28000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 942000.00
TCRT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 28000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Payables: 843000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 921000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
TCRT cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Pretax Income: -1159000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Receivables: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Research And Development: 469000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -923729000.00
TCRT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 718000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Share Issued: 2205846.00
TCRT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 127000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2803000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2803000.00
TCRT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Assets: 3724000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2803000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2803000.00
TCRT income_statement (quarterly, 2025-09-30) — Total Expenses: 1187000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 921000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1039000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
TCRT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -1187000.00
TCRT balance_sheet (quarterly, 2025-09-30) — Working Capital: 1764000.00
TCRT income_statement (annual, 2025-12-31) — +Operating Expense: 4230000.00
TCRT income_statement (quarterly, 2025-12-31) — +Operating Expense: 910000.00
TCRT income_statement (annual, 2025-12-31) — +Total Revenue: 5000.00
TCRT income_statement (quarterly, 2025-12-31) — +Total Revenue: 3000.00
TCRT balance_sheet (annual, 2025-12-31) — Accounts Payable: 613000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 613000.00
TCRT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3000.00
TCRT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7000.00
TCRT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 926773000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 926773000.00
TCRT income_statement (annual, 2025-12-31) — Basic Average Shares: 1948357.00
TCRT income_statement (annual, 2025-12-31) — Basic EPS: -2.20
TCRT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1091000.00
TCRT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1938000.00
TCRT cash_flow (annual, 2025-12-31) — Capital Expenditure: -98000.00
TCRT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1000.00
TCRT balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
TCRT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1385000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1385000.00
TCRT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1385000.00
TCRT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1385000.00
TCRT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3261000.00